News & Updates

Ophthalmologic procedures performed in an outpatient setting do not seem to heighten the risk for acute myocardial infarction (AMI), a study has shown.

Antecedent use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) among older COVID-19 patients with hypertension results in fewer all-cause deaths, whether in-hospital or shortly after discharge, compared with no antecedent use of renin-angiotensin system inhibitors (RASIs), a study has shown.

Among patients with type 2 diabetes mellitus and cardiovascular disease, those with concomitant chronic obstructive pulmonary disease (COPD) are at higher risk of mortality and adverse cardiorenal outcomes, including heart failure, according to post hoc analyses of the EMPA-REG OUTCOME trial. However, these outcomes can be prevented with empagliflozin treatment, regardless of the presence of COPD.

Trajectories of body roundness index (BRI) appear to predict the risk of cardiovascular disease (CVD), particularly among younger adults, suggests a study.

Use of tumour necrosis factor inhibitor (TNFi) does not appear to contribute to incident hypertension in individuals with ankylosing spondylitis (AS), reports a study.

Following an episode of myocardial infarction (MI), patients with light or moderate alcohol consumption appear to have a lower risk of mortality than nondrinkers, according to a study.